v3.26.3
Share-Based Payments (Summary of RSE Activity) (Details) - Restricted Stock Equivalents
shares in Millions
12 Months Ended
Sep. 30, 2026
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Nonvested RSE, Beginning Balance, shares | shares 2.8
Granted, shares | shares 1.5
Vested, shares | shares (0.9)
Canceled, shares | shares (0.3)
Nonvested RSE, Ending Balance, shares | shares 3.1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Nonvested RSE, Beginning Balance, weighted-average grant date estimated fair value | $ / shares $ 34.24
Granted, weighted-average grant date estimated fair value | $ / shares 25.51
Vested, weighted-average grant date estimated fair value | $ / shares 30.17
Canceled, weighted-average grant date estimated fair value | $ / shares 29.15
Nonvested RSE, Ending Balance, weighted-average grant date estimated fair value | $ / shares $ 32.56